24
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Na +/Ca 2+ exchange and Na +/K +-ATPase in the heart

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This paper is the third in a series of reviews published in this issue resulting from the University of California Davis Cardiovascular Symposium 2014: Systems approach to understanding cardiac excitation–contraction coupling and arrhythmias: Na + channel and Na + transport . The goal of the symposium was to bring together experts in the field to discuss points of consensus and controversy on the topic of sodium in the heart. The present review focuses on cardiac Na +/Ca 2+ exchange (NCX) and Na +/K +-ATPase (NKA). While the relevance of Ca 2+ homeostasis in cardiac function has been extensively investigated, the role of Na + regulation in shaping heart function is often overlooked. Small changes in the cytoplasmic Na + content have multiple effects on the heart by influencing intracellular Ca 2+ and pH levels thereby modulating heart contractility. Therefore it is essential for heart cells to maintain Na + homeostasis. Among the proteins that accomplish this task are the Na +/Ca 2+ exchanger (NCX) and the Na +/K + pump (NKA). By transporting three Na + ions into the cytoplasm in exchange for one Ca 2+ moved out, NCX is one of the main Na + influx mechanisms in cardiomyocytes. Acting in the opposite direction, NKA moves Na + ions from the cytoplasm to the extracellular space against their gradient by utilizing the energy released from ATP hydrolysis. A fine balance between these two processes controls the net amount of intracellular Na + and aberrations in either of these two systems can have a large impact on cardiac contractility. Due to the relevant role of these two proteins in Na + homeostasis, the emphasis of this review is on recent developments regarding the cardiac Na +/Ca 2+ exchanger (NCX1) and Na +/K + pump and the controversies that still persist in the field.

          Related collections

          Most cited references258

          • Record: found
          • Abstract: found
          • Article: not found

          Skeletal muscle fatigue: cellular mechanisms.

          Repeated, intense use of muscles leads to a decline in performance known as muscle fatigue. Many muscle properties change during fatigue including the action potential, extracellular and intracellular ions, and many intracellular metabolites. A range of mechanisms have been identified that contribute to the decline of performance. The traditional explanation, accumulation of intracellular lactate and hydrogen ions causing impaired function of the contractile proteins, is probably of limited importance in mammals. Alternative explanations that will be considered are the effects of ionic changes on the action potential, failure of SR Ca2+ release by various mechanisms, and the effects of reactive oxygen species. Many different activities lead to fatigue, and an important challenge is to identify the various mechanisms that contribute under different circumstances. Most of the mechanistic studies of fatigue are on isolated animal tissues, and another major challenge is to use the knowledge generated in these studies to identify the mechanisms of fatigue in intact animals and particularly in human diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

            About half of the 5 million heart failure patients in the United States have diastolic heart failure (clinical heart failure with normal or near-normal ejection fraction). Except for candesartan, no drugs have been tested in randomized clinical trials in these patients. Although digoxin was tested in an appreciable number of diastolic heart failure patients in the Digitalis Investigation Group ancillary trial, detailed findings from this important study have not previously been published. Ambulatory chronic heart failure patients (n = 988) with normal sinus rhythm and ejection fraction > 45% (median, 53%) from the United States and Canada (1991 to 1993) were randomly assigned to digoxin (n = 492) or placebo (n = 496). During follow-up with a mean length of 37 months, 102 patients (21%) in the digoxin group and 119 patients (24%) in the placebo group (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.63 to 1.07; P = 0.136) experienced the primary combined outcome of heart failure hospitalization or heart failure mortality. Digoxin had no effect on all-cause or cause-specific mortality or on all-cause or cardiovascular hospitalization. Use of digoxin was associated with a trend toward a reduction in hospitalizations resulting from worsening heart failure (HR, 0.79; 95% CI, 0.59 to 1.04; P = 0.094) but also a trend toward an increase in hospitalizations for unstable angina (HR, 1.37; 95% CI, 0.99 to 1.91; P = 0.061). In ambulatory patients with chronic mild to moderate diastolic heart failure and normal sinus rhythm receiving angiotensin-converting enzyme inhibitor and diuretics, digoxin had no effect on natural history end points such as mortality and all-cause or cardiovascular hospitalizations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes.

              Oxidative stress is causally linked to the progression of heart failure, and mitochondria are critical sources of reactive oxygen species in failing myocardium. We previously observed that in heart failure, elevated cytosolic Na(+) ([Na(+)](i)) reduces mitochondrial Ca(2+) ([Ca(2+)](m)) by accelerating Ca(2+) efflux via the mitochondrial Na(+)/Ca(2+) exchanger. Because the regeneration of antioxidative enzymes requires NADPH, which is indirectly regenerated by the Krebs cycle, and Krebs cycle dehydrogenases are activated by [Ca(2+)](m), we speculated that in failing myocytes, elevated [Na(+)](i) promotes oxidative stress. We used a patch-clamp-based approach to simultaneously monitor cytosolic and mitochondrial Ca(2+) and, alternatively, mitochondrial H(2)O(2) together with NAD(P)H in guinea pig cardiac myocytes. Cells were depolarized in a voltage-clamp mode (3 Hz), and a transition of workload was induced by beta-adrenergic stimulation. During this transition, NAD(P)H initially oxidized but recovered when [Ca(2+)](m) increased. The transient oxidation of NAD(P)H was closely associated with an increase in mitochondrial H(2)O(2) formation. This reactive oxygen species formation was potentiated when mitochondrial Ca(2+) uptake was blocked (by Ru360) or Ca(2+) efflux was accelerated (by elevation of [Na(+)](i)). In failing myocytes, H(2)O(2) formation was increased, which was prevented by reducing mitochondrial Ca(2+) efflux via the mitochondrial Na(+)/Ca(2+) exchanger. Besides matching energy supply and demand, mitochondrial Ca(2+) uptake critically regulates mitochondrial reactive oxygen species production. In heart failure, elevated [Na(+)](i) promotes reactive oxygen species formation by reducing mitochondrial Ca(2+) uptake. This novel mechanism, by which defects in ion homeostasis induce oxidative stress, represents a potential drug target to reduce reactive oxygen species production in the failing heart.
                Bookmark

                Author and article information

                Journal
                J Physiol
                J. Physiol. (Lond.)
                tjp
                The Journal of Physiology
                BlackWell Publishing Ltd (Oxford, UK )
                0022-3751
                1469-7793
                15 March 2015
                13 March 2015
                : 593
                : Pt 6
                : 1361-1382
                Affiliations
                [1 ]King's College London BHF Centre of Excellence, The Rayne Institute, St Thomas’ Hospital London, SE1 7EH, UK
                [2 ]Cedars Sinai Heart Institute, Cedars Sinai Medical Center Los Angeles, CA, 90048, USA
                [3 ]Department of Pharmacology, University of California Davis, CA, 95616-8636, USA
                [4 ]Department of Physiology, University of Maryland School of Medicine Baltimore, MD, 21201, USA
                [5 ]Division of Cardiology, University of Utah Health Sciences Center, Nora Eccles Harrison Cardiovascular Research and Training Institute Salt Lake City, UT, 84112, USA
                [6 ]Institute for Experimental Medicine, Oslo University Hospital Ullevål Oslo, Norway
                [7 ]Simula Research Laboratory Lysaker, Norway
                [8 ]Department of Biochemistry and Molecular Genetics, University of Chicago Illinois, IL, 60607-7170, USA
                [9 ]Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati Cincinnati, OH, 45267-0524, USA
                [10 ]Department of Physiology, David Geffen School of Medicine at UCLA, University of California Los Angeles, CA, 90095-1751, USA
                [11 ]Department of Cardiovascular Sciences, Division of Experimental Cardiology, KU Leuven, University of Leuven Belgium
                [12 ]Physiology and Pharmacology, University of Toledo Toledo, OH, 43606-3390, USA
                Author notes
                Corresponding author M. J. Shattock: King's College London BHF Centre of Excellence, The Rayne Institute, St Thomas’ Hospital, London SE1 7EH, UK.Email:  michael.shattock@ 123456kcl.ac.uk

                M. J. Shattock and M. Ottolia contributed equally to this work.

                Article
                10.1113/jphysiol.2014.282319
                4376416
                25772291
                ee4338f9-09ce-4463-93d7-4ac05584c119
                © 2014 The Authors. The Journal of Physiology © 2014 The Physiological Society
                History
                : 08 August 2014
                : 30 October 2014
                Categories
                White Papers

                Human biology
                Human biology

                Comments

                Comment on this article